Ose and Boehringer ink €1.1bn deal in immunoncology

04:48 EDT 5 Apr 2018 | European Biotechnology News

Original Article: Ose and Boehringer ink €1.1bn deal in immunoncology

More From BioPortfolio on "Ose and Boehringer ink €1.1bn deal in immunoncology"